RESPIRATORY

July 19, 2017

Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP

Pharmacists are in a key position to recommend de-escalation of antimicrobial therapy based on culture and sensitivity results and to ensure that patients are receiving the appropriate duration of therapy.
July 19, 2017

Two New Medications for Severe Eosinophilic Asthma

Asthma is a common, chronic respiratory disease in which the lung’s airways become inflamed and narrowed.
July 19, 2017

Ethambutol Hydrochloride Compounded Oral Suspension USP (100 mg/mL)

This preparation should be used not as the sole antituberculous drug, but rather in conjunction with one or more others.

July 19, 2017

Smoking-Cessation Services in Community Pharmacies

Tobacco use is the leading preventable cause of death in the United States.
July 19, 2017

Epidemiology of Chronic Lung Diseases

According to the American Lung Association, more than 35 million Americans have a preventable chronic lung disease.
July 19, 2017

The Pharmacist’s Role in the Treatment and Prevention of Acute Mountain Sickness

Untreated, this condition, which is cased by travel to mountainous regions, can progress to high-altitude cerebral or pulmonary edema.
July 19, 2017

Cessation’s Secret Weapon

Armed with the latest treatment modalities, pharmacists are key in reducing smokers’ ranks.

June 16, 2017

Implementing MTM for COPD

MTM can help patients learn how to manage this respiratory condition and decrease complications.